| EPE013 | What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo City Municipality, South Africa, want convenient, tailored platforms | E-poster | Implementation science of scaling up prevention (including PrEP) |
| EPC154 | What is the best policy option for Indonesia to eliminate AIDS in 2030?: The Investment Case Analysis consideration | E-poster | Modelling future healthcare needs |
| EPC284 | What is the added value of incorporating pleasure in sexual health interventions? A systematic review and meta-analysis | E-poster | Sexuality, gender and prevention technologies (including condoms, treatment as prevention, medical male circumcision, pre-exposure prophylaxis) |
| EPA075 | What can we learn from the 2021 Aids Healthcare Foundation-Eswatini mortality profile after meeting the UNAIDS 95-95-95 target? | E-poster | HIV and co-morbidities |
| PESAD13 | What are the practices of people attending erotica shows in terms of psychoactive substance use, sexual behavior and HIV testing? | Poster exhibition | Other populations vulnerable in specific contexts |
| PESUE19 | What are the 12-month retention and viral suppression outcomes for South African ART clients enrolled in DSD models compared to conventional care? | Poster exhibition | Differentiated service delivery for HIV testing, prevention and treatment |
| EPB115 | Weight gain after non-nucleoside reverse transcriptase-to-integrase inhibitor switch in the United States | E-poster | Weight gain |
| EPB110 | Weight gain after antiretroviral therapy initiation in people living with HIV | E-poster | Weight gain |
| EPB119 | Weight changes and pregnancy outcomes among pregnant people living with HIV in use of integrase inhibitors initiated before or after conception: a cohort study | E-poster | Weight gain |
| EPB114 | Weight change when discontinuing integrase strand transfer inhibitors in people living with HIV | E-poster | Weight gain |